Bleakley Financial Group LLC grew its holdings in shares of Rentokil Initial PLC (NYSE:RTO – Free Report) by 28.1% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 78,649 shares of the company’s stock after purchasing an additional 17,258 shares during the period. Bleakley Financial Group LLC’s holdings in Rentokil Initial were worth $2,476,000 at the end of the most recent quarter.
Other institutional investors have also recently made changes to their positions in the company. Caitong International Asset Management Co. Ltd grew its stake in Rentokil Initial by 222.2% during the 4th quarter. Caitong International Asset Management Co. Ltd now owns 1,163 shares of the company’s stock worth $34,000 after buying an additional 802 shares during the last quarter. GAMMA Investing LLC raised its stake in Rentokil Initial by 76.5% in the fourth quarter. GAMMA Investing LLC now owns 1,232 shares of the company’s stock valued at $36,000 after buying an additional 534 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC purchased a new stake in Rentokil Initial in the fourth quarter valued at about $39,000. V Square Quantitative Management LLC boosted its holdings in Rentokil Initial by 84.5% in the first quarter. V Square Quantitative Management LLC now owns 1,395 shares of the company’s stock worth $44,000 after acquiring an additional 639 shares in the last quarter. Finally, IFP Advisors Inc boosted its holdings in Rentokil Initial by 53.8% in the third quarter. IFP Advisors Inc now owns 1,972 shares of the company’s stock worth $50,000 after acquiring an additional 690 shares in the last quarter. Institutional investors and hedge funds own 9.91% of the company’s stock.
Wall Street Analyst Weigh In
Several research firms have recently issued reports on RTO. The Goldman Sachs Group upgraded shares of Rentokil Initial from a “neutral” rating to a “buy” rating in a report on Monday, July 6th. Wall Street Zen upgraded shares of Rentokil Initial from a “hold” rating to a “buy” rating in a research note on Sunday, July 12th. Weiss Ratings reissued a “hold (c)” rating on shares of Rentokil Initial in a research report on Wednesday, June 24th. Finally, Zacks Research lowered shares of Rentokil Initial from a “hold” rating to a “strong sell” rating in a research note on Monday, June 15th. One investment analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, three have assigned a Hold rating and two have assigned a Sell rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $34.50.
Rentokil Initial Stock Performance
Shares of RTO opened at $30.45 on Friday. The company has a quick ratio of 1.07, a current ratio of 1.16 and a debt-to-equity ratio of 0.76. The stock has a 50-day moving average of $30.27 and a two-hundred day moving average of $31.37. Rentokil Initial PLC has a one year low of $22.77 and a one year high of $34.67.
Rentokil Initial Profile
Rentokil Initial PLC is a global business services company specializing in pest control, hygiene and workwear services. Headquartered in Crawley, West Sussex, United Kingdom, the company delivers outsourced solutions designed to protect people, preserve assets and enhance workplaces for both commercial and residential customers.
Under the Rentokil Pest Control brand, the company offers services ranging from routine inspections and treatment of insects, rodents and birds to specialised programmes for food manufacturing and healthcare environments.
Featured Articles
- Five stocks we like better than Rentokil Initial
- Why Abbott Laboratories Stock Is Suddenly Winning Back Wall Street
- Revving Up Returns: Big Banks Race Through the Rate Plateau
- Why Uber’s Biggest Deal Yet Could Unlock Its Next Growth Phase
- Why Microsoft Is Playing a Different AI Game Than Big Tech—and Cash Flow Is the Test
Receive News & Ratings for Rentokil Initial Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rentokil Initial and related companies with MarketBeat.com's FREE daily email newsletter.
